DAILYZ HEALTH NEWS

April 4, 2026 Evan Vega

ASH Highlights PDUFA Dates for Subcutaneous Istuximab in Myeloma, CAR T-Cell Therapy for AML/ALL/MDS

The FDA set an April 23, 2026 PDUFA date for subcutaneous isatuximab in relapsed/refractory multiple myeloma, following positive phase 3 trial results.

Pope Leo XIV, the first American-born pope, photographed in May 2025

Health

April 4, 2026 Evan Vega

Pope Leo XIV’s Good Friday Cross Procession Spotlights Physical Devotion and Spiritual Wellness

Pope Leo XIV’s decision to carry the full wooden cross through all 14 Stations at Rome’s Colosseum drew renewed attention to the connection between physical acts of religious devotion and spiritual wellness.

Health

April 3, 2026 Evan Vega

VA Study: Type 2 Diabetes Patients Quitting GLP-1s Face Reversed Weight Loss and Higher Heart Risks

A VA study found type 2 diabetes patients stopping GLP-1 drugs regained weight and faced a 22% rise in cardiovascular risks.

Health

April 3, 2026 Evan Vega

Denali’s Avlayah Reduces CSF Heparan Sulfate by 91% in Phase 1/2 Trial for MPS II

Denali’s Avlayah reduced cerebrospinal fluid heparan sulfate by 91% in a Phase 1/2 trial for pediatric Hunter syndrome patients.

Health

April 2, 2026 Evan Vega

January-February 2026 (vaccine recommendations, oral GLP-1 approvals, appropriations bill)

The CDC updated childhood vaccine guidelines, reducing routine immunizations from 17 to 11 diseases and shifting six vaccines to high-risk groups.

Health

April 2, 2026 Evan Vega

Would either of these alternatives be helpful?

Linguists and style experts explained that “alternative” implies mutually exclusive choices, while “option” denotes any selectable possibility.

Health

April 1, 2026 Evan Vega

Congress Enacts Most Favored Nation Pricing for Biologics and Specialty Drugs Amid State Price Controls

Congress enacted Most Favored Nation pricing for biologics and specialty drugs on May 12, 2025, aligning U.S. prices with lower international rates.

Health

April 1, 2026 Evan Vega

CMS Finalizes 2.6% Increase in Medicare Hospital Outpatient Payment Rates for CY 2026

CMS finalized a 2.6% increase in Medicare hospital outpatient payment rates for 2026, affecting 4,000 hospitals and 6,000 surgical centers.

Health

March 31, 2026 Evan Vega

Sarcopenic Obesity Combo Raises Death Risk 83%, New Study Warns of Belly Fat and Low Muscle Dangers

A study finds sarcopenic obesity, excess belly fat with low muscle, raises death risk by 83% in adults over 50.

Health

March 31, 2026 Evan Vega

FDA Proposes Reclassifying Mycobacterium Tuberculosis Immunity Tests to Class II Devices

The FDA proposed reclassifying Mycobacterium tuberculosis immunity tests from Class III to Class II devices with new special controls.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

ASH Highlights PDUFA Dates for Subcutaneous Istuximab in Myeloma, CAR T-Cell Therapy for AML/ALL/MDS

Pope Leo XIV’s Good Friday Cross Procession Spotlights Physical Devotion and Spiritual Wellness

VA Study: Type 2 Diabetes Patients Quitting GLP-1s Face Reversed Weight Loss and Higher Heart Risks

Denali’s Avlayah Reduces CSF Heparan Sulfate by 91% in Phase 1/2 Trial for MPS II

January-February 2026 (vaccine recommendations, oral GLP-1 approvals, appropriations bill)

Would either of these alternatives be helpful?

Congress Enacts Most Favored Nation Pricing for Biologics and Specialty Drugs Amid State Price Controls

CMS Finalizes 2.6% Increase in Medicare Hospital Outpatient Payment Rates for CY 2026

Sarcopenic Obesity Combo Raises Death Risk 83%, New Study Warns of Belly Fat and Low Muscle Dangers

FDA Proposes Reclassifying Mycobacterium Tuberculosis Immunity Tests to Class II Devices